Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemfield Cellulose is a prominent Indian manufacturer of pharmaceutical excipients, specializing in cellulose-based derivatives for the global healthcare industry. Established in 1985, the company produces a comprehensive portfolio of binders, disintegrants, and fillers, including Microcrystalline Cellulose (MCC), Sodium Starch Glycolate, and Croscarmellose Sodium. Their manufacturing facilities, located in Nagpur, are designed to meet international quality standards, including WHO-GMP and ISO certifications. Chemfield Cellulose serves a diverse clientele ranging from large multinational pharmaceutical corporations to regional generic manufacturers. By providing high-purity functional ingredients, the company plays a critical role in the formulation and stability of solid dosage forms like tablets and capsules. Their commitment to research and development ensures the production of specialized grades of cellulose to meet evolving drug delivery requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemfield Cellulose.